跳至主要内容
临床试验/CTRI/2022/03/041307
CTRI/2022/03/041307招募中未知

Fecal Microbiota Therapy in Steroid Ineligible Alcoholic Hepatitis: A Randomized Controlled Trial

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Steroid ineligible severe alcoholic hepatitis as per definition
  • 2.Informed consent
  • 3.Age 18 - 70 years
  • 4.Liver biopsy ââ?¬â??if Feasible
  • 5.Model for End-Stage Liver Disease (MELD) ââ?°Â¥ 20 and Maddrey DF ââ?°Â¥ 32
  • Donor evaluation
  • The subjects will be screened for
  • 1. Routine laboratory tests (CBC; LFT; KFT; PT; INR)
  • 2. Fasting blood sugar
  • 3. Lipid profile
  • 5. Anti-HCV
  • 6. HIV 1 & 2
  • 8. Stool routine and microscopy stool ova & cysts.
  • 9. Stool culture
  • 10. Clostridium difficile toxin
  • 11. Helicobacter pylori stool antigen
  • 12. Cryptosporidium & Isospora (acid fast stain)

排除标准

  • 1.UGI Bleed within last one month
  • 2.More then 3 organ failure requiring support
  • 3.Mechanically ventilated patient , (patients requiring ICU/ HDU care) (On inotropic support)
  • 4.Uncontrolled sepsis, DIC
  • 5.Gut paralysis
  • 6.Active hepatic or extra hepatic malignancy
  • 7.Renal failure creatinine > 2.5
  • 8.DF >120
  • 9.MELD >35
  • 10.Prior SBP/active SBP
  • 11.Intestinal conditions like IBD, SIBO
  • Exclusion criteria for Donor
  • 1.Antibiotic usage within 3 months of enrollment
  • 2.Gastroenteritis within last 2 months
  • 4.Diabetes mellitus
  • 5.Inflammatory bowel disease
  • 6.Any Malignancy
  • 7.Chronic Kidney disease, Coronary artery disease
  • 8.Cerebrovascular accident or chronic obstructive pulmonary disease
  • 9.HBsAg, Anti HCV, HIV seropositivity
  • 10.Transaminitis, dyslipidemia
  • 11.Ova or cyst in stool, C. difficile toxin Positive
  • 12.Chronic alcohol intake
  • 13.Active substance abuse

研究者

相似试验

Fecal Transplant in alcoholic liver disease | 临床试验